Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of ICS/LABA combination therapy in asthma

Mahmoud M Mostafa; Christopher F. Rider; N Dulmini Wathugala; Richard Leigh; Mark A. Giembycz; Robert Newton

doi:10.1124/molpharm.120.000146

OtherArticle

Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of ICS/LABA combination therapy in asthma

Mahmoud M Mostafa, Christopher F. Rider, N Dulmini Wathugala, Richard Leigh, Mark A. Giembycz and Robert Newton

Molecular Pharmacology December 29, 2020, MOLPHARM-AR-2020-000146; DOI: https://doi.org/10.1124/molpharm.120.000146

Mahmoud M Mostafa

1Physiology & Pharmacology, University of Calgary, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mahmoud M Mostafa

Christopher F. Rider

2Medicine, University of British Columbia, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christopher F. Rider

N Dulmini Wathugala

1Physiology & Pharmacology, University of Calgary, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard Leigh

3Department of Medicine, University of Calgary, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark A. Giembycz

4Physiology and Pharmacology, University of Calgary, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Newton

4Physiology and Pharmacology, University of Calgary, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Robert Newton
For correspondence: rnewton@ucalgary.ca

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Molecular Pharmacology

Vol. 99, Issue 2

1 Feb 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of ICS/LABA combination therapy in asthma

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherArticle